Unilateral Versus Bilateral Endoscopic Resection of Olfactory Neuroblastoma: Pooled Analysis From Prospective and Retrospective Multicenter Data.

TitleUnilateral Versus Bilateral Endoscopic Resection of Olfactory Neuroblastoma: Pooled Analysis From Prospective and Retrospective Multicenter Data.
Publication TypeJournal Article
Year of Publication2025
AuthorsAbiri A, Nguyen TV, Chen H, Krippaehne E, Lerner DK, Rahman AS, Roozdar P, Rosvall BR, Sabbaj M, Workman AD, Wu S, Adappa ND, Beswick DM, Chang EH, Chang MT, Choby G, Eide JG, Douglas JE, Geltzeiler M, Kohanski MA, Hwang PH, Le CH, Lee JT, Nayak JV, Palmer JN, Patel ZM, Pinheiro-Neto CD, Resnick AC, Smith TL, Snyderman CH, St John MA, Storm PB, Suh JD, Wang MB, Wang EW, Kuan EC
JournalInt Forum Allergy Rhinol
Date Published2025 Jan 15
ISSN2042-6984
Abstract

BACKGROUND: Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy primarily treated with surgery. For tumors arising from the olfactory area, traditional treatment involves transcribriform resection of the anterior cranial fossa. Surgery can be performed with unilateral or bilateral resection depending on extent of involvement; however, there are currently no studies comparing outcomes between the two.

METHODS: Prospective and retrospective data on primary ONB patients were collected from a multicenter registry involving eight academic sites. Propensity score matching (PSM) was used to create patient cohorts with similar baseline characteristics. Cox proportional hazards and Kaplan Meier analyses assessed overall survival (OS). Logistic regression assessed associations between extent of resection (unilateral versus bilateral) and tumor recurrence or postoperative cerebrospinal fluid (CSF) leak.

RESULTS: A total of 187 ONB patients (47.6% female) with an average age of 53.6 ± 15.1 years were analyzed. Most tumors were unilateral (81.3%) and predominantly Kadish C (58.3%) or Hyams II (55.8%). Overall, 56.7% of patients underwent bilateral resection. Fifty-four patients experienced tumor recurrence and nine had postoperative CSF leaks. Following PSM (n = 45/group), extent of resection was not associated with mortality (hazard ratio [HR] 1.73; p = 0.407) or OS (p = 0.400). There was no association between extent of resection and recurrence (odds ratio [OR] 0.90; p = 0.814) or postoperative CSF leak (OR 1.54; p = 0.647).

CONCLUSIONS: For ONB tumors where unilateral resection may be feasible and oncologically sound, the decision for unilateral versus bilateral resection showed no significant effect on survival, recurrence, or postoperative CSF leak. Oncologic outcomes may be comparable when resection is tailored to individual patient and tumor characteristics.

DOI10.1002/alr.23531
Alternate JournalInt Forum Allergy Rhinol
PubMed ID39811891
Grant ListT32GM008620 / NH / NIH HHS / United States
Faculty Reference: 
Eugene H. Chang, MD
Christopher Le, MD, FACS